LYB vs TERN · P/E 21, rev $40.30B vs $6.12B cap
LyondellBasell Industries NV (LYB) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported LYB revenue for 2024-12-31 was $40.30B. Net income was $1.37B. Revenue was down 2.0% from 2023-12-31 to 2024-12-31. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
LYB currently screens at market cap $19.93B and trailing P/E 21.5. TERN currently screens at market cap $6.12B.
Not investment advice. Open the LYB and TERN stock pages for the full models.
Not investment advice.